Health

AIBN researchers are looking at how polymer tadpoles could help improve integrin-targeted therapy for certain cancer stem cells.

A new nanodevice designed by AIBN researchers analyses sugars on the surface of cellular messenger particles to catch early signs of lung cancer.

A first of its kind brain organoid grown at The University of Queensland has helped researchers identify therapies that reduce the impact of COVID-19 on people with Down syndrome.

AIBN researchers scored four wins in the latest Investigator Grant round for nanotechnology projects that could change the way we approach certain diseases.

AIBN researchers are at the heart of a new era for medical research, one that will boost local biomanufacturing and help seriously unwell patients.

Work on a new range of hyper accurate cancer drugs has begun with the launch of an Australian-first research and manufacturing hub.

AIBN Associate Professor Joy Wolfram believes decoding a cellular messaging system will give them the upper hand against a particularly deadly type of breast cancer.

AIBN researcher Dr Nick Fletcher has won an Advance Queensland Industry Research Fellowship to explore localised cell death and the immune response to cancer.

What can the metabolism of 606 people from China, the Netherlands and Australia tell us about the onset and progression of ALS? Turns out, quite a bit.

Ovarian cancer is notoriously difficult to pick up and claims the lives of 1000 women every year. AIBN researchers are hoping to change that with a new, portable blood test.